home / stock / gh / gh message board
Subject | By | Source | When |
---|---|---|---|
GH(-34%/AH)reports results of Shield ctDNA(liquid biopsy)diagnostic for co | DewDiligence | investorshub | 12/16/2022 12:06:13 AM |
I'm still feeling very good about owning this | jerseyboy | investorshub | 04/01/2021 10:10:37 PM |
I like the nice, gradual, consistent rise in | jerseyboy | investorshub | 12/21/2020 10:49:18 PM |
So am I. This is THE company I | jerseyboy | investorshub | 11/27/2020 12:09:11 AM |
2-3 years I'm thinking this is @ 3-5X | PR_12 | investorshub | 11/12/2020 3:48:48 PM |
znewcar1: 27% v3,6M c94.45 f85,754,101 Gap and ran. BO R@.85 | znewcar1 | investorshangout | 03/13/2019 8:22:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / ...
New research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New data show strong performance of Guardant Reveal™ in detection and quantification of residual disease in early-stage breast can...